Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dana-Farber Cancer Institute's Community Benefits activities are informed by the Institute's Community Health Needs Assessment (CHNA) and Community Health Improvement Planning (CHIP) process, conducted every three years to gain a greater
understanding of the health issues facing Boston residents. The following documents fulfill the Institute's CHNA/CHIP obligations as required under Internal Revenue Code Section 501(r)(3)(A)(iii) and the Patient Protection and Affordable Care Act
and supported by the Attorney General's (AGO) Community Benefits Guidelines. The findings of the CHNA reports below have validated Dana-Farber's past and current Community Benefits activities, while identifying opportunities for future initiatives
and continued community engagement.
In 2019, Dana-Farber collaborated with multiple stakeholders to conduct the first city-wide assessment and improvement plan through the Boston CHNA/CHIP Collaborative. The 2019 Boston Collaborative CHNA provides a comprehensive look at a range of health
outcomes and conditions in Boston, as well as the social determinants that affect health. The full report is available at www.bostonchna.org. In 2019, Dana-Farber also collaborated with Boston
Medical Center (BMC) to develop a cancer-specific CHNA report that provides a deeper analysis of issues across the cancer continuum. The health equity analysis used for this assessment confirms the substantial burden of cancer and other health disparities
across DFCI's priority neighborhoods.
As an NCI-designated comprehensive cancer center, Dana-Farber is uniquely qualified to demonstrate measurable outcomes in reducing the cancer burden by building on existing Community Benefits activities and marshaling the collective efforts of local partners
who share our mission. To achieve racial/ethnic health equity across the cancer continuum, Dana-Farber's Community Benefits Office will continue to focus on the following areas:
These areas reflect a commitment to meeting the health needs of medically underserved populations in DFCI's priority neighborhoods and leveraging the hospital's unique role in the continuum of care as a comprehensive cancer center. Additional priorities
will emerge through Dana-Farber's Implementation Plan, which will be completed in November 2019.
Dana-Farber's CHNA documents are available for public review and comment through the links below. For more information, please contact Magnolia Contreras, Director of Community Benefits at Dana-Farber Cancer Institute, at email@example.com or 617-632-3462.
Cancer CHNA Executive Summary
Cancer CHNA Report
Boston CHNA Report
CHNA Implementation Plan
CHNA Executive Summary
CHNA Implementation Plan
Community Benefits 2018 Report
Community Benefits 2017 Report
Dana-Farber is dedicated to meeting the health needs of high-risk and medically underserved populations in our communities.